About This Educational Activity

Title: You and Liver Cancer – An Animated Patient’s Guide to Liver Cancer
Launch date: May 31, 2024

This educational activity has been designed to meet the educational needs of patients and caregivers affected by liver cancer.

This educational activity has been developed by Blue Faery: The Adrienne Wilson Liver Cancer Association in collaboration with Mechanisms in Medicine Inc.

Blue Faery's mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma, through research, education, and advocacy. Our work will improve the quality of life for HCC patients, support their caregivers and give them hope, information, and a voice.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.

Support: This activity is supported by independent educational grants from AstraZeneca, Eisai, Exelixis, Merck, and Genentech.

Faculty:

Ghassan Abou-Alfa, MD, MBA
Attending, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell College at Cornell University
Adjunct Professor, Trinity College Dublin
New York, New York
USA

Amit Singal, MD
Professor of Internal Medicine
Willis C Maddrey, MD Distinguished Chair in Liver Disease
Chief of Hepatology
Medical Director, Liver Tumor Program
UT Southwestern Medical Center
Dallas, Texas
USA

Conflict of Interest Disclosures:

Mechanisms in Medicine Inc. is committed to providing its learners with high-quality educational activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this educational activity:

• Ghassan Abou-Alfa, MD, MBA – Grant support from Agenus, Arcus, AstraZeneca, BioNtech, Bristol Myers Squibb, Elicio, Genentech/Roche, Helsinn, Parker Institute, Pertzye, Puma, QED, and Yiviva. Consulting fees received from AstraZeneca, Autem, Berry Genomics, BioNtech, Boehringer Ingelheim, Bristol Myers Squibb, Eisai, Exelixis, Genentech/Roche, Incyte, Ipsen, Merck, Merus, Neogene, Novartis, Servier, Tempus, Vector, and Yiviva.
• Amit Singal, MD – Consulting fees received from Genentech, AstraZeneca, Bayer, Eisai, Exelixis, Boston Scientific, Sirtex, FufjiFilm Medical Sciences, Exact Sciences, Glycotest, DELFI, GRAIL, and Freenome.

Additional Content Planners: Mechanisms in Medicine Inc. – Staff at Mechanisms in Medicine Inc. have no relevant financial relationships to disclose.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance their own personal development.

• The information presented in this activity is not meant to serve as a guideline for patient management.
• Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should be discussed with your physician.

Technical Requirements:

YouAndLiverCancer.com is an internet-based educational program available on Mac and PC. Click here to view Technical Requirements